Fungitell® Bulletins
2025
Fungitell® Bulletin v11i4 - October 2025
The Use Of (1→3)-β-D-Glucan Testing for Pneumocystis Pneumonia in HIV+ and HIV- Groups
Fungitell® Bulletin v11i3 - July 2025
BG Analytics® Software Update Addition of Estimated pg/mL Values
Fungitell® Bulletin v11i2 - April 2025
(1→3)-β-D-Glucan as an Aid to the Diagnosis of Invasive Fungal Infections in HIV/AIDS Patients
Fungitell® Bulletin v11i1 - January 2025
Serum (1→3)-β-D-Glucan in critically ill patients and the intensive care unit
2024
Fungitell® Bulletin v10i4 - September 2024
(1→3)-β-D-Glucan and Coccidioidomycosis
2023
Fungitell® Bulletin v10i3 - August 2023
Candida Auris and (1→3)-β-D-Glucan
2022
Fungitell® Bulletin v10i2 - February 2022
Clostridium Difficile Infection and Candidemia: Prevalence and Clinical Impact
2021
Fungitell® Bulletin v10i1 - December 2021
Hepatic clearance of (1→3)-β-Glucan: Effects upon circulating BDG titer
Fungitell® Bulletin v9i4 - August 2021
Invasive fungal infection in COVID-19: Prevalence and Diagnostic Challenges
2020
Fungitell® Bulletin v9i3 - November 2020
From Serum to Result in One Hour: Fungitell STAT® Explained
Fungitell® Bulletin v9i2 - October 2020
Application of Fungitell® in Fungal Chorioretinitis and Endophthalmitis
Fungitell® Bulletin v9i1 - April 2020
Influence Of (1→3)-β-Glucan Structure Upon Reactivity
Fungitell® Bulletin v8i4 - April 2020
Storage Stability of (1→3)-β-Glucan In Serum Samples
2019
Fungitell® Bulletin v8i3 - November 2019
Medical Procedure-Related (1→3)-β-Glucan False Positives
Fungitell® Bulletin v8i2 - September 2019
Acute Respiratory Disease Syndrome and Elevated Circulatory (1→3)-β-Glucan
Fungitell® Bulletin v8i1 - March 2019
(1→3)-β-Glucan False Positives: Antibiotics Playing A Role?
2018
Fungitell® Bulletin v7i4 - Decmeber 2018
(1→3)-β-Glucan: An Innate Immune System Biological Response Modifier
Fungitell® Bulletin v7i3 - November 2018
C. Difficile, Enterococcus spp., and Staphylococcus spp: Intestinal Commensal Bacterial Infections and Elevated Serum (1→3)-β-Glucan Titer
Fungitell® Bulletin v7i2 - October 2018
Infections by Rare Fungi, including Entomophthorales: Serum (1→3)-β-Glucan Titer Observations
Fungitell® Bulletin v7i1 - August 2018
Elevated Serum (1→3)-β-Glucan in the Absence of Invasive Fungal Disease
Fungitell® Bulletin v6i4 - May 2018
Combination biomarker performance: Serum (1→3)-β-glucan and other fungal biomarkers - a reference list.
2017
Fungitell® Bulletin v6i3 - Decmeber 2017
Serum (1→3)-β-D-glucan: Fungitell® Negative Predictive Value Update
2016
Fungitell® Bulletin v6i2 - June 2016
Antifungals and Beta-Glucan Sensitivity
Fungitell® Bulletin v6i1 - April 2016
Practice Guideline Recommendations for Serum (1→3)-β-D-glucan in the Diagnosis of IFD
2015
Fungitell® Bulletin v5i4 - August 2015
Pan-fungal screening versus genus/species targeted testing in IFD
Fungitell® Bulletin v5i3 - April 2015
Effect of fungal colonization upon serum (1→3)-β-D-glucan titer
2014
Fungitell® Bulletin v5i2 - July 2014
Role of Negative Predictive Value
Fungitell® Bulletin v5i1 - April 2014
Potential Role of Enteropathogenic Bacteria and Gut Epithelial Barrier Impairment
Fungitell® Bulletin v4i4 - March 2014
Surveillance Fungal Culture Yield in IFD Management
2013
Fungitell® Bulletin v4i3 - December 2013
Diagnostic inaccuracy consequences; Increased morbidity/mortality and costs.
Fungitell® Bulletin v4i2 - August 2013
Bacterial producers of (1→3)-β-D-Glucan: Clinically relevant sources and physiological role of BG
Fungitell® Bulletin v4i1 - 2013
(1→3)-β-D-Glucan and the US fungal meningitis outbreak associated with contaminated methylprednisolone acetate injections
2012
Fungitell® Bulletin v3i4 - 2012
(1→3)-β-D-glucan and Treatment Guidelines for IFD
Fungitell® Bulletin v3i3 - 2012
Clearance of circulating (1→3)-β-D-glucan: Hepatic and renal routes of elimination.
Fungitell® Bulletin v3i2 - 2012
Antifungal Drug Stewardship: Role of high negative predictive value assays in ensuring appropriate therapy.
Fungitell® Bulletin v3i1 - 2012
Non-IFI factors contributing to serum (1→3)-β-D-Glucan positivity.
2011
Fungitell® Bulletin v2i4 - 2011
Role of ingested (1→3)-β-D-Glucan in the stimulation of innate immune responses and potential for translocation.
Fungitell® Bulletin v2i3 - 2011
(1→3)-β-D-Glucan measurement in non-serum matrices.
Fungitell® Bulletin v2i2 - 2011
Healthcare-related Candida infections
Fungitell® Bulletin v2i1 - 2011
Beta-Glucan (BG) Kinetics as a Biomarker
2010
Fungitell® Bulletin v1i4 - December 2010
Aiding the diagnosis of Invasive Fungal Disease
Fungitell® Bulletin v1i3 - September 2010
Aiding the diagnosis of Invasive Fungal Disease
Fungitell® Bulletin v1i2 - June 2010
Aiding the diagnosis of Invasive Fungal Disease
Fungitell® Bulletin v1i1 - March 2010
Aiding the diagnosis of Invasive Fungal Disease